What is he best known for?
The fields of study he is best known for:
Takayuki Sugiura spends much of his time researching Biochemistry, Cannabinoid receptor, Cannabinoid, GPR18 and Cannabinoid receptor type 2.
His Biochemistry study focuses mostly on Arachidonic acid, Receptor, Anandamide, Endocannabinoid system and Ligand.
In Arachidonic acid, Takayuki Sugiura works on issues like Fatty acid, which are connected to Acyl-CoA, Acyltransferase, Transacylation and Lysophospholipids.
His Receptor study incorporates themes from Cell signaling and Lysophosphatidylinositol.
His studies link Endocrinology with Cannabinoid receptor.
His biological study spans a wide range of topics, including Enzyme-linked receptor, Depolarization-induced suppression of inhibition, Pharmacology and Cell biology.
His most cited work include:
- 2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain (1776 citations)
- Leptin-regulated endocannabinoids are involved in maintaining food intake (1378 citations)
- Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor COMPARISON OF THE AGONISTIC ACTIVITIES OF VARIOUS CANNABINOID RECEPTOR LIGANDS IN HL-60 CELLS (337 citations)
What are the main themes of his work throughout his whole career to date?
Takayuki Sugiura mainly focuses on Biochemistry, Cannabinoid receptor, Cannabinoid, Stereochemistry and Receptor.
Takayuki Sugiura frequently studies issues relating to Endocannabinoid system and Cannabinoid receptor.
In his study, AM251 is strongly linked to Endocrinology, which falls under the umbrella field of Cannabinoid.
His study in Stereochemistry is interdisciplinary in nature, drawing from both Ligand, Calcitriol receptor, Microsome, Chemical synthesis and Metabolism.
In his study, GPR55 is inextricably linked to Lysophosphatidylinositol, which falls within the broad field of Receptor.
His studies in Cannabinoid receptor type 2 integrate themes in fields like Cell biology, Depolarization-induced suppression of inhibition, GPR18 and Pharmacology.
He most often published in these fields:
- Biochemistry (55.70%)
- Cannabinoid receptor (26.17%)
- Cannabinoid (26.17%)
What were the highlights of his more recent work (between 2008-2018)?
- Biochemistry (55.70%)
- Cell biology (12.75%)
- Receptor (24.83%)
In recent papers he was focusing on the following fields of study:
Takayuki Sugiura mainly investigates Biochemistry, Cell biology, Receptor, Lysophosphatidylinositol and Ligand.
His study in Biochemistry focuses on Phospholipase A1, Arachidonic acid, Fatty acid, Lysophospholipids and Transacylation.
Takayuki Sugiura has included themes like Sphingomyelin synthase and Sphingomyelin in his Cell biology study.
His Ligand research incorporates elements of Enzyme-linked receptor, Mutant and Molecular biology.
In his research, Cannabinoid is intimately related to Cannabinoid receptor, which falls under the overarching field of Lysophosphatidic acid.
The study incorporates disciplines such as Ketone, Endocrinology and Internal medicine in addition to Stereochemistry.
Between 2008 and 2018, his most popular works were:
- Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms. (128 citations)
- GPR35 is a novel lysophosphatidic acid receptor. (91 citations)
- Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells (71 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Biochemistry, Receptor, Lysophosphatidic acid, Lysophosphatidylinositol and Acyltransferase.
His study in Biochemistry concentrates on Arachidonic acid, Cannabinoid receptor, Phosphatidic acid, Gene isoform and RHOA.
In the field of Cannabinoid receptor, his study on GPR55 overlaps with subjects such as Endogenous agonist.
Takayuki Sugiura has researched Gene isoform in several fields, including Acyltransferases, Glycerophospholipids and Enzyme.
His RHOA research integrates issues from Kynurenic acid, GPR35, G protein-coupled receptor, Lipid signaling and Internalization.
His studies deal with areas such as Polyunsaturated fatty acid, Fatty acid, Acyl-CoA, Lysophospholipids and Transacylation as well as Acyltransferase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
